We can perform any kind of M&S work in the areas of drug absorption and drug-drug interactions. We also analyze PK, PK-PD classical and populations studies in Phases I, II and III.

 Release of four  software is scheduled for June 2026 and first presentation in the 34th PAGE meeting, Dubrovnik, Croatia, 2-6 June 2026 (Welcome to the Population Approach Group in Europe), namely,

i. FTPK Software. Suitable for both modelers and pharmaceutical scientists working in academia or big pharma and generic companies to perform the fitting of PBFTPK models to the concentration-time data.

ii. FTPK+BA Software. Suitable for both modelers and pharmaceutical scientists working in academia or big pharma to perform the PBFTPK fittings as well as the estimation of absolute bioavailability from oral data exclusivel in in early drug development.

iii. FTPK+BE+IVIVC Software. Suitable for both modelers and pharmaceutical scientists working in academia or big pharma and generic companies to perform the fitting of PBFTPK models to the concentration-time data, develop IVIVC based on the F.A.T. concept and analyze bioequivalence data using model dependent and model independent approaches.

iv. FTPK-Population Software. Suitable for modelers in academia and industry to apply nonlinear mixed effect modeling based on PBFTPK structural models.